VEGFA and stroke disorder: While several studies, including meta‐analyses, have reported no association (Campbell et al., 2012; Chong et al., 2025; Cleary et al., 2011; Dalvin et al., 2019; Etminan et al., 2016; Ng et al., 2015; Zarbin et al., 2018), other studies revealed an increased risk of stroke after intravitreal anti‐VEGF agents (Carneiro et al., 2011; Weinstein et al., 2020).